EQL Pharma is a generics- and speciality pharma company, dedicated to providing cost efficient pharmaceuticals for the Nordic markets. This is accomplished with the highest quality standards and streamlined logistic solutions.
Report from the Annual General Meeting of EQL Pharma AB (publ) on May 15th, 2017
Adoption of the balance sheet and income statement, disposition regarding the Company’s results The annual general meeting resolved to adopt the balance sheet and income statement and the consolidated balance sheet and income statement for the financial year 2016. The…
Positive news concerning the pharmaceutical product Kaliumklorid EQL Pharma
The pharmaceutical product Kaliumklorid EQL Pharma (potassium chloride tablets) has today been approved by the Danish Medicines Agency within the framework of a so-called decentralized procedure (a common approval procedure used when more than one country is involved). National approvals…
The Nomination Committee for the Annual General Meeting in 2017
2017-01-23 In accordance with a resolution from the 2016 Annual General Meeting the Nomination Committee shall consist of the Chairman of the Board and one representative for each of the three largest shareholders in terms of voting rights at the end of…
- View all press releases